Dr Geraint Davies

Clinical Infection, Microbiology and Immunology

    Research

    Research Group Membership
    Research Grants

    PanACEA Biomarker Extension Project (PANBIOME)

    EDCTP (NETHERLANDS)

    January 2013 - June 2015

    Randomised trial of high-dose rifampin in patients with new, smear-positive TB

    NATIONAL INSTITUTES OF HEALTH (NIH) (USA)

    August 2011 - July 2017

    Model-based preclinical development of anti-tuberculosis drug combinations (preDICT-TB)

    EUROPEAN COMMISSION

    May 2012 - October 2017

    Population pharmacokinetic-pharmacodynamic modelling to optimise treatments for HIV,TB and malaria

    WELLCOME TRUST (UK)

    November 2008 - October 2012

    Modulation of TB-HIV drug interaction by host genetic influences

    MEDICAL RESEARCH COUNCIL (MRC)

    July 2010 - June 2013

    Wellcome Trust Clinical PhD Programme - Derek Sloan: Understanding mycobacterial persistence in sputum during treatment for tuberculosis

    WELLCOME TRUST (UK)

    August 2009 - July 2012

    Investigation into the relationship between pharmacological and immunological responses to tuberculosis treatment and risk of early death

    THE BRITISH INFECTION ASSOCIATION (UK)

    January 2013 - August 2014

    Adjunctive Rifampicin to Reduce Early mortality from Staphylococcus aureus bacteraemia: a multi-centre, randomised, double blind, placebo controlled trial (the ARREST trial).

    DEPARTMENT OF HEALTH (UK) (NIHR)

    October 2012 - June 2016